CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 701 enrolled
Drug / intervention
Afiya HIV Prevention Intervention +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00279799
NCT00279799Phase 3Completed
CompareCT.gov

HIV Prevention Maintenance for African American Teens

Emory University·interventional·Posted Jan 20, 2006·Updated Nov 19, 2013

In Brief

A Phase 3 clinical trial evaluating Afiya HIV Prevention Intervention and Afiya HIV prevention intervention for Sexually Transmitted Diseases. Completed, enrolled 701 participants across 3 sites.

Detailed Summary

AFIYA aims to reduce both the risk of Sexually Transmitted Infections (STIs) and HIV in young African American females through a culturally and gender appropriate intervention (group sessions) coupled with an individualized HIV Telephone Maintenance Intervention.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSexually Transmitted Diseases
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH)

Timeline

Phase 3CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 20, 2006
Enrollment StartFeb 1, 2005
Primary CompletionFeb 1, 2013
TodayJul 2, 2026
Enrollment to primary: 8 yearsPosted 20.4 years ago

Interventions

Afiya HIV Prevention Interventionbehavioral

Group-based session plus individually tailored HIV prevention phone sessions

Afiya HIV prevention interventionbehavioral

Afiya group-based intervention + nutrition phone sessions (attention control)